Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
AVLN	AVALYN PHARMA INC	$30.28	-1.01%	3.88%	27.55%	-17.22%	-1.78%	N/A	N/A	N/A	N/A	$40.17	$22.24	24.62%	36.15%	0.20	575,000	15.00%
ASMB	ASSEMBLY BIOSCIENCES INC	$21.12	4.66%	3.43%	3.83%	-29.48%	-33.42%	-40.54%	151.61%	-37.37%	-86.46%	$39.71	$19.20	46.81%	10.00%	0.97	319,000	-36.20%
SMMT	SUMMIT THERAPEUTICS INC	$14.15	-6.14%	-13.35%	-8.83%	1.07%	-24.69%	-22.51%	669.02%	172.12%	19.92%	$29.23	$12.07	51.59%	17.23%	0.85	5,480,000	41.16%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$7.25	17.89%	27.64%	26.75%	62.92%	78.57%	73.44%	20.03%	-26.55%	N/A	$7.37	$3.46	1.56%	109.54%	0.94	1,565,000	148.02%
LTGO	LATIGO BIOTHERAPEUTICS INC	$13.11	1.39%	4.05%	-16.55%	-34.65%	N/A	N/A	N/A	N/A	N/A	$25.93	$10.24	49.44%	28.03%	2.13	407,000	142.26%
CRSP	CRISPR THERAPEUTICS AG	$42.24	-0.89%	-15.64%	-15.69%	-21.76%	-19.92%	-17.35%	-18.78%	-50.35%	140.00%	$63.45	$41.75	33.43%	1.17%	1.55	1,866,000	-25.15%
PRTA	PROTHENA CORP PUBLIC LTD CO	$8.16	-0.85%	2.38%	-2.39%	-10.13%	-15.00%	-19.84%	-75.46%	-85.73%	-87.94%	$11.80	$7.73	30.85%	5.56%	1.39	341,000	43.88%
SNDX	SYNDAX PHARMACEUTICALS INC	$9.45	-0.94%	-0.94%	-32.26%	-50.47%	-54.76%	-43.28%	-31.82%	-47.18%	-6.44%	$25.59	$9.11	63.07%	3.73%	0.98	3,180,000	12.37%
RNTX	REIN THERAPEUTICS INC	$0.55	-1.43%	-10.10%	-26.89%	-29.86%	-52.41%	-59.11%	-67.34%	-96.71%	N/A	$2.10	$0.50	73.71%	10.18%	1.11	489,000	40.11%
MNKD	MANNKIND CORP	$4.13	-0.72%	5.90%	35.41%	10.72%	28.66%	-18.54%	16.67%	-13.78%	27.08%	$6.51	$2.23	36.56%	85.20%	1.08	1,687,000	-51.87%
RXRX	RECURSION PHARMACEUTICALS INC	$3.19	-4.35%	-9.52%	-16.95%	-3.78%	4.43%	-26.44%	-45.37%	-83.01%	N/A	$5.24	$2.77	39.22%	14.98%	2.39	16,513,000	-19.72%
PBLS	PARABILIS MEDICINES INC	$28.43	2.67%	-0.35%	5.88%	-20.30%	N/A	N/A	N/A	N/A	N/A	$42.49	$22.66	33.08%	25.46%	0.89	555,000	-23.45%
FBLG	FIBROBIOLOGICS INC	$0.93	-4.24%	-5.41%	-3.44%	-19.39%	-17.96%	-86.19%	N/A	N/A	N/A	$9.60	$0.62	90.34%	49.52%	0.32	35,400	-45.12%
CBIO	CRESCENT BIOPHARMA INC	$14.15	-1.53%	4.51%	9.60%	-14.91%	-27.84%	9.01%	-89.36%	-93.39%	-97.81%	$27.41	$8.72	48.38%	62.27%	1.14	285,000	35.71%
KLRS	KALARIS THERAPEUTICS INC	$1.58	-5.12%	-34.92%	-29.37%	-59.41%	-67.39%	-70.45%	-95.00%	-99.68%	N/A	$11.88	$1.55	86.74%	1.61%	1.33	41,000	-79.50%
TRDA	ENTRADA THERAPEUTICS INC	$5.09	-1.55%	4.09%	4.73%	-31.68%	-30.46%	-42.03%	-68.94%	-85.22%	N/A	$16.45	$4.11	69.06%	23.87%	1.11	792,000	-2.10%
GHRS	GH RESEARCH PLC	$19.10	3.30%	2.63%	1.33%	-32.25%	-12.71%	39.21%	154.67%	-13.57%	N/A	$31.44	$12.04	39.25%	58.64%	1.03	560,000	191.67%
PTHS	PELTHOS THERAPEUTICS INC	$7.44	-7.35%	-20.51%	-63.33%	-74.30%	-71.40%	-78.55%	N/A	N/A	N/A	$34.68	$7.27	78.55%	2.34%	1.09	54,000	-58.46%
MDXG	MIMEDX GROUP INC	$3.21	-0.93%	-3.02%	-31.56%	-23.57%	-8.81%	-57.03%	-47.89%	-58.79%	-66.98%	$7.51	$3.03	57.26%	6.12%	1.15	1,128,000	-23.53%
IPSC	CENTURY THERAPEUTICS INC	$1.65	1.23%	-1.79%	19.57%	-14.51%	-27.63%	254.84%	28.91%	-92.16%	N/A	$3.04	$0.44	45.72%	279.31%	1.35	373,000	-38.75%
NKTR	NEKTAR THERAPEUTICS	$37.27	0.05%	0.03%	-1.71%	-50.91%	-50.93%	-30.92%	453.38%	-81.37%	-82.76%	$109.00	$33.40	65.81%	11.59%	1.70	695,000	-10.32%
PMN	PROMIS NEUROSCIENCES INC	$3.29	-5.46%	-20.91%	-62.01%	-77.76%	-68.87%	-66.28%	-91.23%	N/A	N/A	$27.40	$2.78	87.99%	18.35%	0.60	156,000	31.09%
GNPX	GENPREX INC	$2.08	-5.88%	0.48%	-17.13%	-57.29%	-88.89%	-97.72%	-99.98%	-100.00%	N/A	$98.75	$1.71	97.89%	21.64%	1.14	11,400	-40.00%
NNVC	NANOVIRICIDES INC	$1.23	-8.89%	-6.82%	-6.82%	-9.56%	-28.49%	-8.89%	2.50%	-74.11%	-95.70%	$1.93	$0.85	36.27%	44.71%	1.00	171,000	11.04%
KOD	KODIAK SCIENCES INC	$111.19	2.72%	11.97%	21.35%	178.11%	180.71%	489.24%	6,077.22%	6.32%	N/A	$112.79	$18.15	1.42%	512.79%	1.72	972,000	73.26%
QNTM	QUANTUM BIOPHARMA LTD	$1.61	-9.55%	-23.52%	-44.29%	-50.15%	-70.57%	-79.06%	-97.62%	-98.43%	N/A	$12.42	$1.60	87.04%	0.63%	1.00	86,000	-69.18%
NUVB	NUVATION BIO INC	$3.99	-1.72%	-4.09%	-15.47%	-34.59%	-16.53%	-14.93%	211.72%	-57.19%	N/A	$9.75	$3.95	59.08%	1.14%	1.39	3,085,000	-45.28%
SRRK	SCHOLAR ROCK HOLDING CORP	$43.21	0.10%	-7.96%	6.63%	-18.57%	-13.88%	43.68%	337.30%	22.95%	N/A	$61.76	$35.53	30.04%	21.60%	1.06	624,000	-54.75%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$8.15	4.35%	18.29%	22.01%	22.19%	7.95%	28.55%	N/A	N/A	N/A	$9.32	$5.63	12.55%	44.76%	0.85	774,000	93.98%
CLYM	CLIMB BIO INC	$10.36	-4.69%	0.68%	0.48%	-29.67%	-9.20%	454.01%	303.11%	-42.41%	N/A	$18.33	$1.64	43.48%	533.64%	0.81	668,000	-50.37%
DMRA	DAMORA THERAPEUTICS INC	$21.60	-2.04%	-8.86%	16.38%	-29.71%	-10.60%	-22.41%	50.26%	-75.38%	N/A	$38.33	$15.76	43.64%	37.06%	1.38	475,000	-29.21%
CHRS	COHERUS ONCOLOGY INC	$0.53	-2.42%	-31.82%	-50.93%	-53.95%	-69.21%	-58.33%	-69.48%	-97.23%	-98.13%	$2.62	$0.50	79.93%	4.37%	1.64	4,306,000	-4.42%
MDWD	MEDIWOUND LTD	$12.90	-0.54%	-9.47%	5.56%	-4.66%	-20.62%	-29.82%	63.91%	-45.80%	-65.87%	$19.70	$11.80	34.52%	9.32%	0.73	190,000	-46.48%
ANRO	ALTO NEUROSCIENCE INC	$29.54	-3.53%	17.41%	33.73%	-8.54%	29.28%	160.26%	N/A	N/A	N/A	$37.48	$12.51	21.18%	136.13%	1.24	611,000	-52.60%
KLRA	KAILERA THERAPEUTICS INC	$13.27	0.45%	2.31%	23.21%	-26.15%	-37.14%	N/A	N/A	N/A	N/A	$28.23	$9.76	52.99%	35.96%	1.27	537,000	-4.62%
NXTC	NEXTCURE INC	$6.40	2.73%	20.08%	1.91%	-22.71%	-34.69%	-34.43%	-52.38%	-91.37%	N/A	$15.74	$1.55	59.34%	312.90%	0.86	37,700	-12.33%
MNPR	MONOPAR THERAPEUTICS	$72.00	-0.94%	0.81%	-0.11%	-34.79%	17.19%	-17.25%	4,515.38%	196.30%	N/A	$124.42	$50.07	42.13%	43.80%	0.84	203,000	-35.14%
VBIO	VALION BIO INC	$0.53	3.93%	3.73%	-65.87%	-87.61%	-97.81%	-98.98%	-99.94%	-100.00%	N/A	$67.50	$0.47	99.22%	11.84%	0.99	97,000	16.87%
IBRX	IMMUNITYBIO INC	$6.02	-0.82%	-30.28%	-38.57%	-21.31%	-26.13%	201.00%	75.00%	-15.69%	-19.73%	$12.43	$1.95	51.57%	208.72%	2.09	13,296,000	-36.76%
VOGX	VOGENX INC	$16.67	-12.95%	-4.47%	-0.54%	18.31%	N/A	N/A	N/A	N/A	N/A	$38.41	$12.95	56.60%	28.73%	1.37	94,000	-10.48%
CRMD	CORMEDIX INC	$4.66	-3.72%	-12.41%	-36.94%	-42.75%	-37.87%	-58.43%	49.84%	-10.38%	-48.51%	$13.02	$4.65	64.21%	0.22%	1.13	2,392,000	-35.02%
PLRZ	POLYRIZON LTD	$11.05	-3.75%	0.05%	13.45%	2.79%	-27.21%	139.07%	N/A	N/A	N/A	$18.20	$2.88	39.29%	283.68%	0.24	5,700	-71.07%
STTK	SHATTUCK LABS INC	$4.65	-3.33%	0.65%	-15.30%	-36.48%	-31.11%	152.72%	146.03%	-62.74%	N/A	$8.33	$1.86	44.18%	150.67%	1.39	776,000	-41.21%
BCYC	BICYCLE THERAPEUTICS PLC	$3.37	-2.32%	-6.65%	-7.16%	-15.33%	-28.90%	-48.94%	-75.42%	-94.49%	N/A	$7.83	$3.26	56.96%	3.37%	1.11	604,000	-4.13%
VTVT	VTV THERAPEUTICS INC	$19.69	-4.83%	-6.37%	-30.25%	-36.18%	-37.82%	-37.03%	38.27%	-68.24%	-90.27%	$44.00	$19.32	55.25%	1.92%	0.91	17,400	-75.49%
CADL	CANDEL THERAPEUTICS INC	$6.20	-26.10%	-29.14%	-33.12%	-47.46%	-30.65%	34.49%	581.32%	-38.06%	N/A	$14.00	$4.35	55.71%	42.53%	1.22	6,622,000	242.22%
FRMM	FORUM MARKETS INC	$2.16	-8.47%	-28.95%	-48.45%	-65.38%	-51.57%	-86.65%	-97.56%	-99.99%	N/A	$14.64	$1.76	85.25%	22.73%	1.38	145,000	-66.59%
ASBP	ASPIRE-LAKEWOOD HOLDINGS INC	$8.41	0.12%	3.96%	2.81%	18.28%	58.68%	-93.34%	-99.94%	N/A	N/A	$205.20	$3.31	95.90%	154.16%	0.73	13,100	-5.76%
KARD	KARDIGAN INC	$13.82	-2.12%	-10.95%	6.55%	-36.63%	N/A	N/A	N/A	N/A	N/A	$27.00	$12.23	48.81%	13.00%	1.84	411,000	18.79%
VANI	VIVANI MEDICAL INC	$1.01	2.75%	-5.61%	-14.41%	-24.63%	-12.93%	-25.46%	-0.98%	-87.62%	-98.06%	$1.66	$0.80	39.19%	26.25%	0.86	366,000	-73.71%
UNCY	UNICYCIVE THERAPEUTICS INC	$3.55	-2.47%	0.00%	-4.83%	-34.26%	-58.28%	-33.40%	-34.27%	-86.65%	N/A	$8.74	$3.33	59.38%	6.61%	0.74	680,000	-14.47%
ZBIO	ZENAS BIOPHARMA INC	$28.01	1.34%	-0.88%	11.33%	-4.08%	40.54%	-21.45%	N/A	N/A	N/A	$44.60	$13.50	37.20%	107.48%	1.28	305,000	-59.44%
HUMA	HUMACYTE INC	$0.56	-6.22%	24.55%	55.43%	1.45%	-50.62%	-53.11%	-75.20%	-94.78%	N/A	$1.52	$0.34	63.29%	65.58%	1.76	4,623,000	-11.93%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$1.70	1.19%	-1.16%	-29.17%	-59.04%	-60.28%	28.79%	-83.43%	-97.80%	N/A	$6.95	$1.28	75.54%	32.81%	1.70	1,297,000	-20.18%
BLSM	BLOSSOMHILL THERAPEUTICS INC	$14.02	-5.53%	3.85%	-9.43%	-14.25%	N/A	N/A	N/A	N/A	N/A	$27.99	$11.02	49.91%	27.22%	2.00	223,000	-12.89%
BSEM	BIOSTEM TECHNOLOGIES INC	$1.05	-19.23%	-7.08%	-53.33%	-66.13%	N/A	N/A	N/A	N/A	N/A	$5.44	$0.90	80.70%	16.67%	1.94	450,000	12.22%
DMAC	DIAMEDICA THERAPEUTICS INC	$8.79	-5.79%	-6.09%	12.40%	30.22%	40.42%	62.18%	275.64%	118.11%	N/A	$11.00	$5.25	20.09%	67.59%	0.94	214,000	13.83%
CRDF	CARDIFF ONCOLOGY INC	$0.73	0.00%	-8.75%	-27.72%	-25.81%	-56.80%	-66.05%	-29.13%	-86.53%	-99.66%	$3.31	$0.71	77.95%	2.82%	1.56	205,000	-34.71%
EQ	EQUILLIUM INC	$1.29	-2.27%	-14.57%	-2.27%	-35.82%	-44.16%	53.57%	158.00%	-77.01%	N/A	$3.54	$0.81	63.56%	58.87%	0.74	469,000	180.84%
ALXO	ALX ONCOLOGY HOLDINGS INC	$1.04	-3.70%	-9.96%	6.12%	-46.39%	-48.77%	-14.75%	-87.66%	-97.76%	N/A	$2.66	$0.86	60.90%	20.65%	1.37	673,000	-56.04%
CGTX	COGNITION THERAPEUTICS INC	$0.68	0.59%	-1.02%	-15.21%	-34.62%	-43.33%	-55.84%	-33.98%	-94.10%	N/A	$1.81	$0.55	62.43%	23.64%	1.36	263,000	-24.43%
QUIT	ACHIEVE LIFE SCIENCES INC	$6.32	0.48%	-5.95%	-9.71%	-12.83%	6.04%	37.99%	50.48%	-21.98%	-99.33%	$8.64	$2.62	26.85%	141.22%	1.05	776,000	-3.36%
SRZN	SURROZEN INC	$31.61	-0.19%	1.97%	34.45%	33.21%	4.88%	160.81%	485.37%	-77.82%	N/A	$37.83	$12.52	16.44%	152.48%	0.74	107,000	-20.15%
TTRX	TURN THERAPEUTICS INC	$9.35	-7.75%	-1.42%	-11.84%	-5.22%	133.04%	128.48%	N/A	N/A	N/A	$16.45	$2.57	43.19%	263.62%	1.44	92,000	-7.07%
KRSA	KORSANA BIOSCIENCES INC	$31.65	1.18%	1.93%	-0.03%	15.64%	44.45%	213.99%	105.52%	-91.60%	N/A	$59.36	$7.19	46.68%	340.44%	1.01	226,000	34.52%
RNXT	RENOVORX INC	$1.04	-10.34%	-7.96%	-9.57%	-17.46%	22.50%	6.78%	-0.95%	-87.10%	N/A	$2.59	$0.73	59.85%	42.08%	0.95	815,000	74.52%
LGVN	LONGEVERON INC	$2.49	-16.16%	37.57%	15.81%	-64.31%	-67.02%	-63.90%	-98.62%	-99.24%	N/A	$12.30	$1.31	79.76%	90.08%	1.16	60,400	-23.54%
WVE	WAVE LIFE SCIENCES INC	$3.13	-0.79%	-6.98%	-0.32%	-39.81%	-55.22%	-53.07%	-39.69%	-30.75%	-91.62%	$21.73	$3.00	85.60%	4.33%	1.40	2,654,000	7.32%
ALMS	ALUMIS INC	$5.60	-8.65%	-7.13%	-14.63%	-77.06%	-77.47%	6.06%	N/A	N/A	N/A	$31.35	$5.44	82.14%	2.94%	1.07	1,492,000	-19.96%
BHVN	BIOHAVEN LTD	$13.82	-1.78%	-4.56%	21.02%	-6.94%	53.05%	71.04%	-51.96%	N/A	N/A	$18.24	$7.99	24.23%	72.97%	1.57	1,253,000	-23.08%
SLDB	SOLID BIOSCIENCES INC	$6.84	-2.29%	3.79%	17.53%	-24.67%	-7.32%	59.07%	216.67%	-78.99%	N/A	$11.45	$4.16	40.26%	64.42%	1.38	975,000	-26.30%
ODTX	ODYSSEY THERAPEUTICS INC	$19.14	-4.78%	-0.47%	11.02%	-7.63%	6.69%	N/A	N/A	N/A	N/A	$29.05	$15.10	34.11%	26.75%	1.01	323,000	0.31%
ENGN	ENGENE THERAPEUTICS INC	$2.41	5.70%	37.71%	47.85%	42.60%	56.49%	-71.39%	-72.77%	N/A	N/A	$12.25	$1.40	80.33%	72.14%	0.38	3,697,000	-68.96%
ANIX	ANIXA BIOSCIENCES INC	$2.62	-2.24%	-17.61%	-1.87%	-18.13%	-9.66%	-40.32%	-11.78%	-42.42%	-50.57%	$5.46	$2.32	52.01%	12.93%	1.00	279,000	1.09%
GUTS	FRACTYL HEALTH INC	$0.90	11.33%	-2.80%	-77.54%	-88.62%	-92.06%	-93.27%	N/A	N/A	N/A	$29.34	$0.80	96.92%	13.00%	1.29	422,000	141.14%
CING	CINGULATE INC	$4.30	-4.23%	0.94%	-8.90%	-13.83%	-12.60%	29.13%	-94.22%	N/A	N/A	$11.89	$3.16	63.84%	36.08%	1.04	177,000	145.83%
GRCE	GRACE THERAPEUTICS INC	$1.81	0.00%	-2.16%	-9.05%	-12.56%	-19.56%	-41.61%	-15.81%	-81.03%	-97.29%	$5.18	$1.67	65.06%	8.38%	0.73	13,600	-84.00%
AKTX	AKARI THERAPEUTICS PLC	$6.80	4.45%	-7.73%	-13.92%	-2.86%	115.87%	-67.31%	-95.00%	-99.48%	-99.90%	$29.32	$3.02	76.81%	125.54%	0.63	21,400	47.59%
CRVO	CERVOMED INC	$1.69	-7.65%	19.01%	-25.55%	-42.32%	-54.57%	-76.69%	-82.63%	-94.76%	-99.96%	$10.00	$1.27	83.10%	33.07%	0.99	632,000	-80.09%
ACRV	ACRIVON THERAPEUTICS INC	$1.45	-0.68%	-9.94%	-17.14%	-21.62%	-24.48%	-29.95%	-68.20%	N/A	N/A	$3.56	$1.27	59.27%	14.17%	1.57	194,000	-42.09%
CLDX	CELLDEX THERAPEUTICS INC	$28.83	1.05%	-3.48%	2.05%	-32.34%	-11.32%	21.54%	6.90%	-32.97%	-60.93%	$45.14	$22.33	36.13%	29.11%	1.25	544,000	-37.25%
SPRY	ARS PHARMACEUTICALS INC	$3.89	2.10%	39.43%	-3.95%	-36.23%	-51.44%	-53.75%	-2.75%	-55.24%	N/A	$13.15	$2.44	70.42%	59.43%	1.07	1,297,000	-43.34%
FATE	FATE THERAPEUTICS INC	$1.28	-4.48%	-30.25%	-36.00%	-49.21%	-40.05%	29.03%	-35.68%	-97.62%	-53.28%	$3.23	$0.95	60.37%	34.60%	1.72	1,807,000	-51.00%
PCVX	VAXCYTE INC	$63.37	-2.04%	-0.81%	-5.13%	7.66%	16.81%	39.12%	30.88%	142.98%	N/A	$90.75	$42.40	30.17%	49.46%	0.85	623,000	-41.88%
KYMR	KYMERA THERAPEUTICS INC	$127.57	0.31%	-3.16%	19.58%	11.49%	49.05%	100.49%	751.60%	108.11%	N/A	$142.92	$62.91	10.74%	102.78%	1.61	808,000	17.96%
GLSI	GREENWICH LIFESCIENCES INC	$14.94	-2.23%	-1.52%	-3.61%	-8.79%	-40.95%	82.20%	45.19%	-57.45%	N/A	$34.10	$7.78	56.19%	92.03%	1.41	74,000	-64.25%
SABS	SAB BIOTHERAPEUTICS INC	$2.96	-3.90%	-2.31%	10.45%	-21.07%	-25.25%	-4.52%	-68.17%	-96.88%	N/A	$5.15	$2.44	42.52%	21.31%	0.79	658,000	-68.84%
ALLO	ALLOGENE THERAPEUTICS INC	$0.84	1.45%	-19.33%	-34.96%	-57.63%	-63.99%	-30.08%	-65.33%	-95.55%	N/A	$4.46	$0.82	81.19%	2.32%	1.59	11,661,000	9.10%
VYGR	VOYAGER THERAPEUTICS INC	$1.73	1.76%	-7.49%	-19.53%	-46.27%	-58.31%	-56.53%	-72.45%	-49.42%	-86.93%	$5.48	$1.59	68.42%	9.15%	1.35	807,000	-42.03%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$0.68	1.80%	-7.13%	-26.33%	-73.35%	-72.37%	-59.70%	-61.31%	-94.80%	N/A	$3.82	$0.64	82.28%	5.62%	0.67	234,000	10.38%
ELTX	ELICIO THERAPEUTICS INC	$1.50	-3.85%	-0.66%	-15.25%	-52.38%	-86.73%	-83.53%	-74.53%	-96.44%	N/A	$16.00	$1.25	90.63%	20.00%	0.91	327,000	40.34%
DRTS	ALPHA TAU MEDICAL LTD	$13.38	0.15%	-2.48%	-2.62%	-7.72%	38.80%	246.09%	331.61%	34.88%	N/A	$15.79	$3.43	15.26%	290.09%	0.61	404,000	-34.09%
GOSS	GOSSAMER BIO INC	$10.97	-2.40%	12.28%	12.40%	-19.48%	-60.09%	-94.54%	-78.22%	-98.82%	N/A	$309.60	$8.29	96.46%	32.33%	1.45	124,000	-34.39%
SEPN	SEPTERNA INC	$42.60	1.77%	-12.79%	16.98%	-5.63%	72.12%	121.41%	N/A	N/A	N/A	$53.34	$21.31	20.13%	99.91%	1.22	333,000	-45.32%
PLRX	PLIANT THERAPEUTICS INC	$0.70	-5.81%	-13.95%	-28.00%	-35.46%	-40.43%	-59.48%	-94.58%	-95.75%	N/A	$1.72	$0.69	59.48%	1.01%	0.98	877,000	67.05%
ENTA	ENANTA PHARMACEUTICALS INC	$10.99	-1.88%	-0.09%	-4.60%	-18.23%	-21.67%	-6.23%	34.35%	-87.77%	-65.09%	$17.15	$10.05	35.92%	9.35%	0.97	128,000	-50.00%
PTN	PALATIN TECHNOLOGIES INC	$6.23	-5.18%	-0.64%	-23.93%	-37.70%	-62.36%	-42.31%	-93.80%	-98.75%	-99.09%	$31.00	$4.51	79.90%	38.14%	1.16	30,200	123.70%
PHVS	PHARVARIS NV	$33.36	-1.39%	-3.00%	11.13%	-2.00%	1.28%	37.51%	97.98%	109.81%	N/A	$43.25	$23.01	22.87%	44.98%	0.52	183,000	-51.33%
JSPR	JASPER THERAPEUTICS INC	$13.68	2.32%	-18.86%	-8.06%	-47.17%	-50.44%	-71.68%	-93.06%	-99.48%	N/A	$72.60	$9.45	81.16%	44.72%	0.89	16,500	-49.07%
GENB	GENERATE BIOMEDICINES INC	$12.07	-3.98%	-7.58%	-1.51%	-19.69%	-25.59%	N/A	N/A	N/A	N/A	$22.67	$11.00	46.76%	9.73%	1.80	792,000	-50.75%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Xeris Biopharma Holdings (NASDAQ:XERS)

Xeris Biopharma Holdings (NASDAQ:XERS) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 15 points higher than the biotech industry average of 24.

XERS passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 129.48% over the past year, overperforming other biotech stocks by 225 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 2.04% from Xeris Biopharma Holdings's current stock price of $16.66.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

REGN passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 37.48% over the past year, overperforming other biotech stocks by 133 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $904.29, a downside of -5.36% from Regeneron Pharmaceuticals's current stock price of $955.47.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 24 analysts covering Regeneron Pharmaceuticals, 58.33% have issued a Strong Buy rating, 8.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Fennec Pharmaceuticals (NASDAQ:FENC) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Fennec Pharmaceuticals (NASDAQ:FENC) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

FENC passed 17 out of 33 due diligence checks and has strong fundamentals. Fennec Pharmaceuticals has seen its stock return 51.11% over the past year, overperforming other biotech stocks by 147 percentage points.

Fennec Pharmaceuticals has an average 1 year price target of $16.67, an upside of 43.43% from Fennec Pharmaceuticals's current stock price of $11.62.

Fennec Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Fennec Pharmaceuticals, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 8 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)

Rallybio (NASDAQ:RLYB) has an annual dividend yield of 86.26%, which is 73 percentage points higher than the biotech industry average of 12.82%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.74%, which is -6 percentage points lower than the biotech industry average of 12.82%.

Oramed Pharmaceuticals's dividend payout ratio of 7.1% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.45%, which is -8 percentage points lower than the biotech industry average of 12.82%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 48.3% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 0.7% over the last week. Oragenics was the among the top losers in the biotechnology industry, dropping -42.86% yesterday.

Oragenics shares are trading lower. The stock initially rallied yesterday after the company announced it had been granted an extension to regain NYSE compliance, but it has since reversed.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.55% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -14.28% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

3. Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics (NASDAQ:ZVRA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zevra Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Zevra Therapeutics's stock has dropped -1.63% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

Are biotech stocks a good buy now?

62.71% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.98% over the next year.

2.25% of biotech stocks have a Zen Rating of A (Strong Buy), 3.83% of biotech stocks are rated B (Buy), 44.82% are rated C (Hold), 36.71% are rated D (Sell), and 12.39% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.